Fate Therapeutics (FATE) Shares Issued (2014 - 2024)

Fate Therapeutics has reported Shares Issued for 11 years, with the latest figure at -$54.5 million in Q4 2024.

• For the quarter ending Q4 2024, Shares Issued fell 20479.25% year-over-year to -$54.5 million; the trailing twelve-month figure through Sep 2025 stood at -$54.5 million (down 173.43% YoY), and the FY2024 full-year result was $20.0 million, changed N/A from the prior year.
• Shares Issued for Q4 2024 stood at -$54.5 million, down from $54.5 million in the prior quarter.
• The five-year high for Shares Issued was $137.8 million in Q3 2020, with the low at -$179.1 million in Q4 2020.
• Historically, Shares Issued has averaged $2.3 million across 5 years, with a median of $2.8 million in 2022.
• The largest YoY upside for Shares Issued was 7167.44% in 2020 against a maximum downside of 131612.5% in 2020.
• Fate Therapeutics' Shares Issued stood at -$179.1 million in 2020, then surged by 88.46% to -$20.7 million in 2021, then soared by 107.34% to $1.5 million in 2022, then plunged by 117.47% to -$265000.0 in 2023, then plunged by 20479.25% to -$54.5 million in 2024.
• The last three Shares Issued figures came in at -$54.5 million (Q4 2024), $54.5 million (Q2 2024), and $20.0 million (Q1 2024), per Business Quant data.